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Background: Cardiac rhythm management devices (CRMD) require a ventricular lead to be placed across the tricuspid valve. Tricuspid valve 
incompetence and regurgitation (TR) has been an under-recognized clinical complication of ventricular lead implantation and its clinical 
significance is not fully known. We studied the incidence of hospitalizations for congestive heart failure exacerbation (CHFE) among patients that 
experienced worsening TR following a ventricular lead implantation.
methods: We retrospectively reviewed 148 patients (age 68±15) that received a CRMD. TR and pulmonary artery systolic pressure (PASP) measured 
by Doppler echocardiography before and after CRT device implantation were analyzed. TR was graded on a scale from 0-4. Patients were classified 
according to the change in grade of TR after device implantation as follows: none (<1), mild (1), and moderate to severe (≥2). Hospitalizations for 
CHFE after device implantation were counted.
results: Patient groups were comparable with regards to baseline characteristics. Mean follow-up time was 32±14 months. One hundred (68%) 
patients had no change, 36 (24%) had mild and 12 (8%) moderate to severe increase in TR after CRMD implantation. Patients that experienced a 
moderate to severe change in TR had significantly higher incidence of hospitalizations (1.4±0.8) compared to patients that had mild (0.72±0.9) 
or no increase (0.5±1) in TR (p=<0.01). Patients with a moderate to severe increase in TR had a greater change in PASP (13mmHg; p=0.002) after 
device implantation compared to those with mild (4mmHg; p=0.02) or no increase in TR (0.8mmHg).
conclusion: Increased TR following a CRMD implant is relatively common (48 out of 148 implants, 32%) and correlated with subsequent risk of 
hospitalization for heart failure. Certainly, lead related valve incompetence may contribute to worsening TR after CRMD implantation. The association 
between change in TR and change in PASP suggests that worsening of left heart function may further exacerbate valve incompetence after device 
implantation.
